Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.3390/molecules25245986
Twittear
Título: | A compressive review about Taxol® : history and future challenges |
Fecha de publicación: | 17-dic-2020 |
Editorial: | MDPI |
Cita bibliográfica: | Molecules (2020) 25, 5986 |
ISSN: | 1420-3049 |
Palabras clave: | Drug Cancer Cell death Biotechnology Antitumor agent |
Resumen: | Taxol®, which is also known as paclitaxel, is a chemotherapeutic agent widely used to treat different cancers. Since the discovery of its antitumoral activity, Taxol® has been used to treat over one million patients, making it one of the most widely employed antitumoral drugs. Taxol® was the first microtubule targeting agent described in the literature, with its main mechanism of action consisting of the disruption of microtubule dynamics, thus inducing mitotic arrest and cell death. However, secondary mechanisms for achieving apoptosis have also been demonstrated. Despite its wide use, Taxol® has certain disadvantages. The main challenges facing Taxol® are the need to find an environmentally sustainable production method based on the use of microorganisms, increase its bioavailability without exerting adverse effects on the health of patients and minimize the resistance presented by a high percentage of cells treated with paclitaxel. This review details, in a succinct manner, the main aspects of this important drug, from its discovery to the present day. We highlight the main challenges that must be faced in the coming years, in order to increase the effectiveness of Taxol® as an anticancer agent. |
Autor/es principal/es: | Gallego Jara, Julia Lozano Terol, Gema Sola Martinez, Rosa Alba Cánovas Diaz, Manuel De Diego Puente, María Teresa |
Facultad/Departamentos/Servicios: | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Bioquímica y Biología Molecular B e Inmunología |
URI: | http://hdl.handle.net/10201/136505 |
DOI: | https://doi.org/10.3390/molecules25245986 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 24 |
Derechos: | info:eu-repo/semantics/openAccess Attribution-NonCommercial-NoDerivatives 4.0 International |
Descripción: | ©2020. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Published, version of a Published Work that appeared in final form in Molecules. To access the final edited and published work see https://doi.org/10.3390/molecules25245986 |
Aparece en las colecciones: | Artículos: Bioquímica y Biología Molecular "B" e Inmunología |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
A44-Molecu..6.pdf | 2,64 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons